期刊文献+

结膜下注射AMD 3100对小鼠角膜碱烧伤血管新生的治疗作用 被引量:1

Effects of subconjunctival injected AMD 3100,a specific antagonist of CXCR4,on alkali-induced corneal neovascularization in mice
原文传递
导出
摘要 目的探讨结膜下注射AMD 3100对小鼠角膜碱烧伤血管新生的治疗作用及其机制。方法采用碱烧伤法诱导小鼠角膜血管新生(CNV)形成。在碱烧伤后当天,治疗组和对照组分别在球结膜下注射AMD 3100 5μg(10μL)和生理盐水(10μL),每日1次,连续用药7 d。裂隙灯显微镜下观察不同时间点角膜炎症指数。病理组织学检查观察炎症细胞数量,并采用免疫组化检测角膜组织微血管密度。结果实验组在碱烧伤后不同时间点的炎症指数、炎症细胞数量和微血管密度均明显少于对照组(P<0.05)。结论AMD 3100可有效抑制CNV,可能与减轻碱烧伤后炎症反应有关。 Objective To investigate the anti-angiogesis effects of subconjunctival injectedAMD 3100 on alkali-induced corneal neovascularization in mice. Methods Alkali burn was applied to induce the formation of cornea neovasculafization (CNV) in mice. On the day after alkali bum, AMD 3100 5 μg ( 10 μL) and normal saline 10 μl were respectively injected into subconjunctival tissue of mice, one time every other day, seven times in total. Corneal inflammation index was observed under slit lamp at different time points. The numbers of inflammatory cells were detected by histopathological examination, and microvessel density (MVD) in the cornea was observed by immunohistochemistry. Results At different time points after alkali burn, corneal inflammation index, inflammatory cells and MVD of experimental group were significant- ly less than of the control group ( P 〈 0. 05 ). Conclusion AMD3100 can effectively inhibit the growth of CNV, which may be a result of the decrease of inflammatory response after alkali bum.
作者 彭亮红 柳林
出处 《眼外伤职业眼病杂志》 2010年第3期161-165,共5页 Journal of Injuries and Occupational Diseases of the Eye with Ophthalmic Surgeries
关键词 AMD 3100 角膜碱烧伤 角膜血管新生 AMD3100 alkuli burn corneal neovasculariza- tion
  • 相关文献

参考文献14

  • 1Tachibana K, Hirota S, lizasa H, et al. The cmokine receptor CX- CR4 is essential for vascularization of the gastrointestinal tract [ J ]. Nature, 1998, 393 (6685) : 591-549.
  • 2Mirshahi F, Pourtau J, Li H, et al. SDF-1 activity on microvascular endothelial cells: cnosequences on angiogenesis in in vitro and in vivo mdoels[ J]. Thromb Res, 2000, 9(6) : 578-549.
  • 3De Clercq E. The bicyclam AMD 3100 story[J]. Nat Rev Drug Discoy, 2003, 2(7) : 581-587.
  • 4Matthys P, Hatse S, Vermeire, et al. AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4,inhibits autoimmune joint inflammation in IFN-γreceptor-deficient mice. J Immunology, 2001,167(8) : 4686-4692.
  • 5Blanco J, Barretina J, Henson C, et al. The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiencyvirus type 1 envelope -induced apoptasis[ J]. Antimicrob Agents Chemother, 2000, 44( 1 ) :51-56.
  • 6Lukaes NW, Berlin A, Schols D, et al. AMD 3100,a CXCR4 antagonist, attenuate allergic lung inflammation and airway hypereaetivity [J]. Am J Pathol, 2002, 160(4) : 1353-1360.
  • 7Ueno M, Lyons BL, Burzenski LM, et al. Accelerated wound healing of alkali-burned corneas in MRL mice is associated with a reduced inflammatory signature[ J]. Invest ophthalmol Vis Sci, 2005,46( 11 ) : 4097-4106.
  • 8Ormerod LD, Abelson MB, Kenyon KR. Standard models of corneal injury using alkali-immersed filter dises[J]. Invest Ophthalrnol Vis Sei. 1989, 30(10) : 2148-2153.
  • 9孙秉堂,徐锦堂.角膜病的理论基础与临床[M].北京:科学技术出版社,1994:132.
  • 10Conners MS, Urbano F, Vafeas C, et al. Alkali burn-induced synthesis of inflamematory eicosanoids in rabbit corneal Invest Ophthalmol Vis Sci, 1997, 38: 1963-1971.

同被引文献31

  • 1Asahara T,Murohara T,Sulliven A,et al.Isolation of putative progenitor endothelial cells for angiogenesis.Science,1997,275:964-1167.
  • 2Peichev M,Naiyer AJ,Pereira D,et al.Expression of VEGFR-2 and CD133 by circulating human CD34(+)cells identifies a Dopulation of functional endothelial precursors.Blood,2000,95:952-958.
  • 3Li B,Sharpe E,Maupin AB,et al.VEGF and PIGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.FASEB J,2006,20:1495-1497.
  • 4Goon PK,Lip GY,Stonetake PS,et al.Circulating endothelial ceIIs and circulating progenitor cells in breast cancer:relationship to endothelial damage/dysfunction/apoptosis,clinicopathologic factors,and the Nottingham Prognostic Index.Neoplasia,2009,11:771-779.
  • 5Franz RW,Parks A,Shah KJ,et al.Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease.J Vasc Surg,2009,50:1378-1390.
  • 6Yu JX,Huang XF,Lv WM,et al.Combination of stromalderived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemie neovascula rjzation.J Vasc Surg,2009,50:608-616.
  • 7Jeong JO,Kim MO,Kim H,et al.Dual angiogenic and neurotrophie effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy.Circulation,2009,119:699-708.
  • 8Li Caizi S.Neu MB,Shaw LC,et al.Epcs and pathological angiogensis:when good cells go bad.Microvasc Res,2010,79:207-216.
  • 9Brunner S,Sehernthaner GH,Satler M,et al.Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy first in vivo data.Invest Ophthalmol Vis ScI,2009,50:392-398.
  • 10Losordo DW,Dimmeler S.Therapeutle angiogenesis and vasculogenesis for isehemic disease:Part Ⅱ:cell-based therapies.Circulation,2004,109:2692-2697.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部